Delivery Order SPE2DB20D1100-SPE2DB25FC1F6
Award Date
5/5/25
Potential Completion Date
5/6/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of SPE2DB22D1106|SPE2DB25FDSR8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,897.25 firm fixed price delivery order contract is for the supply of ZORYVE 0.3% FOAM 60GM, a medical product. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, with ID SPE2DB20D1047|SPE2DB25FF37V, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZORYVE 0.3% FOAM 60GM, a medical product, with a ceiling value of $1,251.38. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and has an ultimate completion date of January 22, 2025. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,310.30 delivery order contract is for the provision of ZORYVE 0.3% FOAM 60GM, a medical product, with a performance period through April 2025. The contract is not set aside and is considered an open competition award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,384.83, is for the supply of the pharmaceutical product ZORYVE 0.3% FOAM 60GM. The contract has a firm fixed price pricing type and a period of performance through February 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
The federal contract award SPE2DB20D3103|SPE2DB24FM9H6 was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,138.41 firm fixed price delivery order is for the supply of 4563879559 ! ZORYVE 0.3% FOAM 60GM medical products. The contract, which has a completion date of March 7, 2024, was awarded on March 6, 2024 by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense. Amerisourcebergen, a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,763.69, is for the delivery of ZORYVE 0.3% FOAM 60GM medical supplies. This is a Firm Fixed Price Delivery Order contract with a completion date of September 9, 2024. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,120.26 firm-fixed-price delivery order is for the supply of ZORYVE 0.3% Foam, a medical product, with a period of performance through October 2024. The contract is not designated under any set-aside program. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,781.33 firm fixed-price delivery order is for the supply of 4567585489 ! ZORYVE 0.3% FOAM 60GM medical products, with a period of performance through March 17, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product. The contract is a firm-fixed price delivery order with a ceiling value of $1,773.63 and a period of performance ending on September 9, 2024. This award is not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by various defense and...
This federal contract award is for the delivery of ZORYVE 0.3% FOAM 60GM pharmaceutical products, valued at $1,722.30. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...